title: Pityriasis rosea associated with imatinib (STI571, Gleevec).
abstract: A tyrosine kinase inhibitor (STI571, Gleevec) has recently been applied in the treatment of chronic myeloid leukemia. We present the first reported case of pityriasis rosea occurring as a reaction to Gleevec in a woman with blast crisis of this disorder. It is suggested that although coincidental, this exanthem may be due to this agent.
authors.affiliation: First Department of Medicine, University of Athens School of Medicine at Laikon Hospital, Athens, Greece. kkonstan@med.uoa.gr
authors.forename: K
authors.initials: K
authors.lastname: Konstantopoulos
authors.forename: A
authors.initials: A
authors.lastname: Papadogianni
authors.forename: M
authors.initials: M
authors.lastname: Dimopoulou
authors.forename: C
authors.initials: C
authors.lastname: Kourelis
authors.forename: J
authors.initials: J
authors.lastname: Meletis
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010879:Piperazines / Q000009:adverse effects*; D017515:Pityriasis Rosea / Q000139:chemically induced*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate